Weekly Recap | BTI.US -0.87%, consensus target above spot
I'm LongbridgeAI, I can summarize articles.British American Tobacco (BTI.US) closed the week at $59.48, down 0.87%, while the S&P 500 slipped 0.47%. That put BTI about 0.4 percentage points behind the benchmark. The five sessions were choppy: a dip to $58.51 on Monday, a slow recovery on Tuesday and Wednesday, a push to $60.505 on Thursday, then a fade back to $59.48 on Friday. Weekly amplitude came to 3.58%.
The Week
British American Tobacco (BTI.US) closed the week at $59.48, down 0.87%, while the S&P 500 slipped 0.47%. That put BTI about 0.4 percentage points behind the benchmark. The five sessions were choppy: a dip to $58.51 on Monday, a slow recovery on Tuesday and Wednesday, a push to $60.505 on Thursday, then a fade back to $59.48 on Friday. Weekly amplitude came to 3.58%.
Key Events
The corporate story this week centred on buybacks and shareholder positioning. On Monday the company disclosed a £28.28 million share repurchase. On Friday, a regulatory filing showed Capital Group had raised its voting rights in BTI from 17.93% to 18.02%; the stock opened lower and fell more than 2% intraday. No material operational or regulatory announcements appeared among the week’s filings, so the buyback and the institutional stake increase were the main thread.
Analyst Ratings
Seven brokers cover the name: five rate it buy, one overweight and one hold, with no underweight or sell ratings. The consensus is strong buy, with an average target of $70.36667, about 18.30% above the latest price. Targets span $63 to $75, suggesting limited disagreement. BTI ranks third out of ten names in its industry group.
The Week Ahead
The US macro calendar is busy next week: durable goods orders, FHFA house prices, the Case Shiller home price index, new home sales, the Richmond Fed index and consumer confidence all land on Tuesday, with the Dallas Fed manufacturing index due Monday. On the company side, the next scheduled event is the FY2026 annual report in February 2027, where estimates point to EPS of $4.7993 and revenue of $35 billion.
In Short
This week’s dip sat alongside a constructive ratings setup: consensus target stands 18.30% above spot, with valuation at roughly 15.15x P/E and 2x P/B, a moderate range. The latest session’s flows showed large lots net buying while mid and small lots were mixed, so no uniform direction emerged. The next question is how the week’s macro releases shape risk appetite, and whether high-dividend names like BTI keep attracting allocation-driven demand.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.